日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial data.

MK-6194（一种旨在选择性激活调节性 T 细胞的 IL-2 突变体）的安全性、药代动力学和药效学：单次递增剂量和多次递增剂量试验数据

期刊:Immunohorizons
影响因子:
doi:10.1093/immhor/vlaf005
Scheid Johannes F, Cunningham-Bussel Kiki, Kim Nancy, Agarwal Shiuli, Nieddu Garrett, Cote Josee, Lemoine Lieselotte, Decaesteker Tatjana, Mendez Luis, Paul Erina, Love-Gregory Latisha, Contreras Alejandra Virginia, Zhao Xuemei, Franco-Dilone Lucia, Pang Ling, Baltus Gretchen A, Beaumont Maribel, Shah Ketal, Higginson-Scott Nathan, Kis-Toth Katalin, Otipoby Kevin L, Viney Joanne L, Sicard Eric, Rottey Sylvie, Sundy John S, Van Dyck Kristien, Laethem Tine, Larson Patrick, Sutradhar Santosh, Wnek Richard, Bueters Tjerk, Lai Eseng, Stoch S Aubrey, Iwamoto Marian, Robbins Jonathan A
细胞生物学
发表日期：2025
文献求助 收藏

Comparative Analysis of Multiplex Platforms for Detecting Vitreous Biomarkers in Diabetic Retinopathy

糖尿病视网膜病变玻璃体生物标志物检测多重检测平台的比较分析

期刊:Translational Vision Science & Technology
影响因子:2.6
doi:10.1167/tvst.9.10.3
Lamy, Ricardo; Farber-Katz, Suzette; Vives, Franklin; Ayanoglu, Gulesi; Zhao, Tong; Chen, Yi; Laotaweerungsawat, Sawarin; Ma, Dahui; Phone, Audrey; Psaras, Catherine; Li, Nina Xiaoyan; Sutradhar, Santosh; Carrington, Paul E; Stewart, Jay M
糖尿病视网膜病变
视网膜病变
神经科学
代谢
糖尿病
发表日期：2020
文献求助 收藏

Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial

在随机 MONALEESA-2 试验中，比较了瑞博西尼联合来曲唑与单用来曲唑治疗激素受体阳性、HER2 阴性老年乳腺癌患者的疗效。

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-017-4523-y
Sonke, Gabe S; Hart, Lowell L; Campone, Mario; Erdkamp, Frans; Janni, Wolfgang; Verma, Sunil; Villanueva, Cristian; Jakobsen, Erik; Alba, Emilio; Wist, Erik; Favret, Anne M; Bachelot, Thomas; Hegg, Roberto; Wheatley-Price, Paul; Souami, Farida; Sutradhar, Santosh; Miller, Michelle; Germa, Caroline; Burris, Howard A
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2018
文献求助 收藏

Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2

接受瑞博西尼+来曲唑治疗的激素受体阳性、人表皮生长因子受体2阴性的绝经后晚期乳腺癌女性的健康相关生活质量：MONALEESA-2 研究结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-018-4769-z
Verma, Sunil; O'Shaughnessy, Joyce; Burris, Howard A; Campone, Mario; Alba, Emilio; Chandiwana, David; Dalal, Anand A; Sutradhar, Santosh; Monaco, Mauricio; Janni, Wolfgang
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2018
文献求助 收藏

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

塞瑞替尼治疗ALK重排非小细胞肺癌患者的疗效和安全性（ASCEND-1）：多中心、开放标签、1期试验的最新结果

期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(15)00614-2
Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Jürgen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Sutradhar, Santosh; Li, Siyu; Szczudlo, Tomasz; Yovine, Alejandro; Shaw, Alice T
肺癌
肿瘤
肿瘤免疫
ALK
ASC
细胞生物学
发表日期：2016
文献求助 收藏

Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial

噻托溴铵用于既往未接受维持治疗的中度慢性阻塞性肺疾病患者：一项随机安慰剂对照试验

期刊:npj Primary Care Respiratory Medicine
影响因子:4.7
doi:10.1038/npjpcrm.2014.3
Troosters, Thierry; Sciurba, Frank C; Decramer, Marc; Siafakas, Nikos M; Klioze, Solomon S; Sutradhar, Santosh C; Weisman, Idelle M; Yunis, Carla
慢性阻塞性肺疾病
发表日期：2014
文献求助 收藏

Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis

采用积极的多因素干预措施降低心血管风险的效果在居住在亚太地区和非亚太地区的患者中是一致的：一项 CRUCIAL 试验的亚组分析

期刊:Vascular Health and Risk Management
影响因子:2.8
doi:10.2147/VHRM.S54586
Cho, Eun Joo; Kim, Jae Hyung; Sutradhar, Santosh; Yunis, Carla; Westergaard, Mogens
发表日期：2014
文献求助 收藏

Bazedoxifene versus oral bisphosphonates for the prevention of nonvertebral fractures in postmenopausal women with osteoporosis at higher risk of fracture: a network meta-analysis

巴泽多昔芬与口服双膦酸盐预防绝经后骨质疏松症高危女性非椎体骨折的疗效比较：一项网络荟萃分析

期刊:
影响因子:
doi:10.1016/j.jval.2014.01.008
Ellis, Alexandra G; Reginster, Jean-Yves; Luo, Xuemei; Cappelleri, Joseph C; Chines, Arkadi; Sutradhar, Santosh; Jansen, Jeroen P
骨质疏松
代谢
骨折
发表日期：2014
文献求助 收藏

Proactive multifactorial intervention strategy reduces the risk of cardiovascular disease estimated with region-specific risk assessment models in Pacific Asian patients participating in the CRUCIAL trial

在参与 CRUCIAL 试验的亚太裔患者中，积极主动的多因素干预策略可降低使用区域特异性风险评估模型估算的心血管疾病风险。

期刊:Journal of Korean Medical Science
影响因子:2.3
doi:10.3346/jkms.2013.28.12.1741
Cho, Eun Joo; Kim, Jae Hyung; Sutradhar, Santosh; Yunis, Carla; Westergaard, Mogens
心血管疾病
心血管
发表日期：2013
文献求助 收藏

Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial

在一项随机对照试验中，对接受治疗的高血压患者同时采用氨氯地平/阿托伐他汀单片疗法，以达到血压和血脂目标并降低心血管风险负担。

期刊:Vascular Health and Risk Management
影响因子:2.8
doi:10.2147/vhrm.s7710
Grimm, Richard; Malik, Mobin; Yunis, Carla; Sutradhar, Santosh; Kursun, Attila
心血管
高血压
发表日期：2010
文献求助 收藏